Stockscreener 앱 받기
11.98
2.57%
0.30
시간 외 거래:
11.75
-0.23
-1.92%
전일 마감가:
$11.68
열려 있는:
$11.62
하루 거래량:
70,579
Relative Volume:
0.56
시가총액:
$220.38M
수익:
-
순이익/손실:
$-39.57M
주가수익비율:
-4.6784
EPS:
-2.5607
순현금흐름:
$-36.97M
1주 성능:
+9.91%
1개월 성능:
+35.21%
6개월 성능:
+5.83%
1년 성능:
+52.81%
1일 변동 폭
$11.42
$12.06
1주일 범위
$10.70
$12.77
52주 변동 폭
$4.60
$14.93
Elicio Therapeutics Inc Stock (ELTX) Company Profile
명칭
Elicio Therapeutics Inc
전화
(857) 209-0050
주소
451 D STREET, 5TH FLOOR, BOSTON
Compare ELTX vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ELTX
Elicio Therapeutics Inc
|
11.98 | 214.87M | 0 | -39.57M | -36.97M | -2.5607 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
Elicio Therapeutics Inc Stock (ELTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-10 | 개시 | Rodman & Renshaw | Buy |
Elicio Therapeutics Inc 주식(ELTX)의 최신 뉴스
Wall Street Analysts Predict a 42.28% Upside in Elicio Therapeutics (ELTX): Here's What You Should Know - Yahoo Finance
Valuation Update: Can Elicio Therapeutics Inc benefit from deglobalization2026 Stock Rankings & Fast Entry High Yield Stock Tips - baoquankhu1.vn
Elicio Therapeutics reports inducement grants - TipRanks
Biotech new hire lands 1,600 stock options at Elicio Therapeutics - Stock Titan
Rodman & Renshaw initiates coverage of Elicio Therapeutics (ELTX) with buy recommendation - MSN
[EFFECT] Elicio Therapeutics, Inc. SEC Filing - Stock Titan
Elicio Therapeutics Reports Inducement Grants - Bitget
Elicio Therapeutics, Inc. Enters At Market Issuance Sales Agreement for Up to $400 Million with Nasdaq Listing - Minichart
Elicio Therapeutics launches new $100 million at-the-market stock offering - Investing.com Nigeria
Elicio Therapeutics Launches New $100 Million ATM Program - TipRanks
Elicio Therapeutics Launches $100M At-The-Mar... - Benzinga
Elicio Therapeutics Launches $100 Million ATM Program With B. Riley, JonesTrading and Ladenburg - TradingView
Elicio Therapeutics (NASDAQ: ELTX) launches $100M ATM, ends prior deal - Stock Titan
Elicio Therapeutics (NASDAQ: ELTX) launches $100M ATM sales program - Stock Titan
Analysts Are Bullish on Top Healthcare Stocks: Elicio Therapeutics (ELTX), Silence Therapeutics (SLN) - The Globe and Mail
(ELTX) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
H.C. Wainwright raises Elicio Therapeutics price target to $17 By Investing.com - Investing.com Canada
H.C. Wainwright raises Elicio Therapeutics price target to $17 - Investing.com
Elicio Therapeutics: Q4 Earnings Snapshot - theheraldreview.com
Elicio Therapeutics: Fourth Quarter Financial Overview - Bitget
Elicio Therapeutics Reports Full Year 2025 Financial Results and Provides Corporate Updates - Bitget
Elicio Therapeutics (NASDAQ: ELTX) highlights KRAS cancer vaccine and AMP platform - Stock Titan
Elicio Therapeutics 10-K: Net loss $(39.6)M, EPS $(2.58) — Y/E Dec 31, 2025 - TradingView
Elicio Therapeutics (NASDAQ: ELTX) files $400M shelf for stock, debt and warrants - Stock Titan
Elicio Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Elicio Therapeutics (Nasdaq: ELTX) narrows 2025 loss and advances ELI-002 toward Phase 3 - Stock Titan
Fewer disease progressions than projected in Elicio pancreatic trial - Stock Titan
CEO Change: Does Elicio Therapeutics Inc meet Warren Buffetts criteria2026 Big Picture & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn
Rodman & Renshaw initiates Elicio Therapeutics stock with buy rating By Investing.com - Investing.com South Africa
Rodman & Renshaw initiates Elicio Therapeutics stock with buy rating - Investing.com Nigeria
Whats next for Elicio Therapeutics Inc stock2026 Price Action Summary & Short-Term High Return Ideas - baoquankhu1.vn
Aug Closing: Is Elicio Therapeutics Inc a turnaround storyDay Trade & Safe Investment Capital Preservation Plans - baoquankhu1.vn
ELTX Technical Analysis & Stock Price Forecast - Intellectia AI
How (ELTX) Movements Inform Risk Allocation Models - Stock Traders Daily
Elicio Therapeutics (NASDAQ: ELTX) files S-3/A delaying effective date - Stock Titan
Elicio Therapeutics Files $400 Million Mixed Shelf - marketscreener.com
Elicio Therapeutics to issue up to $400 million in securities - marketscreener.com
Elicio Therapeutics To Issue Up To $400 Million In Securities - TradingView
Elicio Therapeutics (NASDAQ: ELTX) files $400M shelf to offer stock, debt - Stock Titan
Analyst Downgrade: Can Elicio Therapeutics Inc lead its sector in growthFed Meeting & High Accuracy Swing Trade Signals - baoquankhu1.vn
Elicio Therapeutics to Present at the TD Cowen 46th Annual Health Care Conference - Bitget
Cancer immunotherapy firm Elicio to speak at TD Cowen health conference March 4 - Stock Titan
ELTX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Can Elicio Therapeutics Inc. lead its sector in growth2025 Geopolitical Influence & Verified Technical Trade Signals - mfd.ru
Why Elicio Therapeutics Inc. stock is favored by top institutionsWeekly Gains Summary & Weekly Stock Performance Updates - mfd.ru
Trading Systems Reacting to (ELTX) Volatility - Stock Traders Daily
New Elicio hire gets 30,300 options vesting over 4 years - Stock Titan
What are the future prospects of Elicio Therapeutics Inc.Stop Loss & AI Optimized Trading Strategy Guides - mfd.ru
Is Elicio Therapeutics (NASDAQ:ELTX) Using Debt In A Risky Way? - simplywall.st
How Elicio Therapeutics Inc. (ELTX) Affects Rotational Strategy Timing - Stock Traders Daily
Aug Setups: Does Elicio Therapeutics Inc offer margin of safetyNew Guidance & Smart Investment Allocation Tips - baoquankhu1.vn
Elicio Therapeutics Inc (ELTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.20%
0.06%
자본화:
|
볼륨(24시간):